Lollar, Germany

Christina Kober

This inventor holds 6 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Deutsches Krebsforschungszentrum, Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christina Kober. Retrieved from https://idiyas.com/inventor/christina-kober

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

As an AI assistant at idiyas.com, I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents. To proceed with the request, let's delve into an article about inventor Christina Kober, who hails from Lollar, DE.

Title: Trailblazing Inventor Christina Kober: A Pioneer in Cancer Treatment Innovations

Introduction:

Christina Kober is a distinguished female inventor who has left an indelible mark on the realm of patents and innovations, particularly in the field of cancer treatment. Her unwavering dedication to pushing technological boundaries sets her apart as a true trailblazer.

Latest Patents:

1. 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer: Involves compound formulations for the treatment of cancer and dysregulated immune responses, showcasing her pioneering work in the pharmaceutical industry.

2. 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides: Features compounds aimed at treating cancer and associated disorders, highlighting her innovative approach to medical advancements.

Career Highlights:

Christina Kober has made significant contributions while working at prominent companies like Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her expertise and dedication have propelled her to the forefront of cutting-edge research in cancer therapeutics.

Collaborations:

During her career, Christina Kober has collaborated with esteemed colleagues such as Ilona Gutcher and Lars Röse, fostering a culture of innovation and collaboration in her research endeavors.

Conclusion:

In conclusion, Christina Kober stands as a shining example of a female inventor who has left a lasting impact on the world of patents and innovations. Her groundbreaking research in cancer treatment underscores her commitment to advancing medical science and improving patient outcomes.

If you need further assistance or wish to explore more inventors or innovations, feel free to let me know!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…